The latest thought leadership from our expert teams

Active filters (1)
スケールダウンしたモデル化による堅牢なバイオプロセスの構築
eBook

Creating robust bioprocessing scale-down models

May 18, 2021

Scale-down models have become an increasingly common development tool, especially in the bioprocessing industry. Read our eBook to discover our approach to the challenge of scaling up scale down models.

  • Bioinnovation
Whitepaper

Building the business of biodesign

Mar 27, 2018

Synthetic biology remains nascent, yet full of promise. The idea of using rational engineering approaches to design biology has the potential to solve some of humanity’s biggest challenges, such as securing food supplies...

  • Bioinnovation
  • Innovation management
  • Product realisation
  • Strategic advice
Biotech
Opinion

From glowing flowers to decomposing buildings – it was an illuminating week for biotech in the Bay Area

May 17, 2022

From almost three years of pandemic restrictions to a three-day biology bonanza. Senior Biomedical Engineer Ellen Simmons gets back on the live conference trail with a visit to Built With Biology, formerly SynBioBeta. Here she shares her experiences – and enthusiasm for helping to drive the biotech ecosystem forwards… 

  • Bioinnovation
  • Sustainability
  • Synthetic biology
The Engine venture ecosystem
Opinion

CC and The Engine venture ecosystem: an alignment of ambition

Apr 28, 2022

Our brand relaunch has landed just as we ramp up our commitment to The Engine, the ambitious venture capital firm spun out of MIT (Massachusetts Institute of Technology) to support ‘Tough Tech’ companies and solve key challenges in climate change, human health and advanced systems. What’s particularly energizing is that as a strategic partner, we get to engage with founders of disruptive start-ups who are so passionate, driven and mission focused. The alignment with our own renewed purpose couldn’t be stronger. 

  • AI & Analytics
  • Bioinnovation
  • Connectivity & IoT
  • Robotics
  • Sensing
Beyond BioData 2021
Opinion

Beyond BioData 2021 – a data sharing vision to improve diagnosis, treatment and wellbeing

Nov 26, 2021

Fresh from an in-person visit to BioData World Conference 2021, Andrew Goulter discusses the role big pharma is playing in unlocking a complex new healthcare ecosystem. His hope? That effective data sharing and democratised access will deliver advantages for healthcare professionals and patients alike… 
 

  • Bioinnovation
  • Digital health
  • Human factors
Webinar

Accelerating biotech product development

Nov 16, 2021

Cambridge Consultants' Mike Dunkley, SVP, Bioinnovation, hosts a panel with industry leaders from Kytopen, CATALOG and Galy to explore transformative technologies for cell transfection, lab-grown cotton and DNA data storage. 

  • Bioinnovation
細胞治療にかかる費用や時間の負担は減らせるのか?
Opinion

Can cell therapy become cheaper and easier?

Nov 9, 2021

Cell and gene therapy is hailed as the future of 21st century medicine but is currently too expensive to be widely used. As a principal scientist in bioinnovation, I’ve been part of a team addressing this issue in an ambitious project with exciting potential…

  • AI & Analytics
  • Bioinnovation
  • Human factors
  • Mechanical engineering
PureSentry:リアルタイムコンタミネーション検出が細胞治療にもたらす変革
Whitepaper

PureSentry: Can real-time contamination detection transform cell therapy manufacture?

Nov 9, 2021

PureSentry: Can real-time contamination detection transform cell therapy manufacture? 

  • AI & Analytics
  • Bioinnovation
  • Human factors
  • Mechanical engineering
  • Physical sciences
Whitepaper

Turning trash to cash: microalgae cultivation to mitigate environmental waste impact

Oct 21, 2021

This paper explains how ‘turning trash into cash’ provides opportunity for companies to gain first-mover advantage in several fields. With a clear, problem/solution approach, it outlines a method that be considered simply as a way to capture carbon – but is more likely to yield benefits in the creation of valuable bio-derived compounds.

  • Bioinnovation
  • Sustainability
Webinar

Europe as an innovation powerhouse in ophthalmology

Aug 5, 2021

Luis Diaz-Santana, Head of Ophthalmology at Cambridge Consultants, presented at OIS European Showcase virtual conference. Watch his presentation to hear his thoughts on if Europe really is an innovation powerhouse in ophthalmology.

  • Bioinnovation
  • Human factors
  • Physical sciences
Opinion

Our sustainable materials database is enabling innovation in the drive to net zero

Jun 10, 2021

The ambition to reduce or eliminate single-use plastics from the world’s supply chains is of course as laudable as it is essential. I’m proud to be part of a team of colleagues dedicated to doing something about it – by creating a guide that is helping innovators switch to alternatives.

  • Bioinnovation
  • Innovation management
  • Product realisation
  • Sustainability
Opinion

Let’s go! The new Catapult consortium is a brilliant boost for cell and gene therapy manufacturing

Jun 8, 2021

We’re thrilled to be a part of the CGT Catapult, working with 20 brilliant companies to accelerate the technology development for cell and gene therapy manufacturing. 

  • Bioinnovation